Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
50M
-
Number of holders
-
71
-
Total 13F shares, excl. options
-
13.7M
-
Shares change
-
+324K
-
Total reported value, excl. options
-
$244M
-
Value change
-
+$13.4M
-
Number of buys
-
43
-
Number of sells
-
-29
-
Price
-
$17.81
Significant Holders of KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) as of Q4 2019
87 filings reported holding KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share as of Q4 2019.
KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) has 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.7M shares
of 50M outstanding shares and own 27.36% of the company stock.
Largest 10 shareholders include SV Health Investors, LLC (1.72M shares), EVENTIDE ASSET MANAGEMENT, LLC (1.68M shares), FMR LLC (1.67M shares), BlackRock Inc. (861K shares), Polar Capital LLP (659K shares), PICTET ASSET MANAGEMENT LTD (622K shares), VHCP Management III, LLC (620K shares), VANGUARD GROUP INC (550K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (500K shares), and Ghost Tree Capital, LLC (415K shares).
This table shows the top 71 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.